This study is creating a collection of information and samples from people with interstitial lung disease (ILD), which are conditions that cause scarring of the lungs. This includes conditions like sarcoidosis, idiopathic pulmonary fibrosis, pulmonary fibrosis, and hypersensitivity pneumonitis. The goal is to better understand these diseases, find ways to diagnose them earlier, and discover new treatment targets. You may be able to join if you are 18 or older, are a patient at TUKHS (The University of Kansas Health System), and are being followed for an autoimmune disease, ILD, or other rare lung diseases. The study is collecting clinical data and biological samples over a period of up to 10 years to help with research.

Study design

This is an observational study, meaning participants are not given any specific intervention or treatment. It aims to enroll 1000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants' data and samples will be collected from enrollment up to 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.